Quantum Cyber N.V. launches $100 million at-the-market share offering
The company entered a sales agreement with Titan Partners Securities to sell ordinary shares from time to time under an existing shelf registration.
Quantum Cyber N.V. disclosed in an 8-K that on October 9, 2026, in connection with the launch of an "at the market" offering program, the company entered into a sales agreement with Titan Partners Securities LLC, as sales agent.1 Under the agreement, the company may sell, from time to time, an aggregate of up to $100,000,000 of its ordinary shares, nominal value €0.01 per share.1
The shares will be offered through the agent pursuant to the company's shelf registration statement on Form S-3, File No. 333-296480, initially filed with the SEC on June 4, 2026 and declared effective by the SEC on June 15, 2026.1 The company also filed a prospectus supplement dated October 9, 2026 under Rule 424(b) covering the offer and sale of the shares under the sales agreement.1
The filing states the company intends to use net proceeds to fund capital expenditures and software development related to its motor, propeller and quantum antenna lines, to fund software development related to its operating system, to fund expansion of production capacity and product offerings including through potential acquisitions, investments or strategic partnerships or joint ventures, and for working capital and general corporate purposes.1
The company is not required to sell any shares: it may, subject to the terms of the sales agreement, sell shares from time to time but is not obligated to do so, while the agent will use commercially reasonable efforts to sell shares on the company's behalf.1 Sales may occur through methods including direct sales on the Nasdaq Capital Market or other existing trading markets, to or through a market maker, or in negotiated transactions.1
Compensation terms were disclosed: the company agreed to pay the agent a commission equal to 3.0% of the gross sales price of shares sold, and agreed to reimburse the agent for certain specified expenses.1 A legal opinion from CMS Derks Star Busmann N.V. relating to the shares was filed as an exhibit to the report.1 The 8-K was signed by David Lazar, Chief Executive Officer, on October 9, 2026.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.